comparemela.com

Martin Strel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ALJAZAM Inside Story October 2, 2015

Some people are stopping pills, medications altogether. Is there going to be a desire for shareholder value, prescriptions and profits . Its the inside story. Welcome to inside story. Im ray suarez. In the past few weeks, americans have been treated to the spectacle of an unapologetic corporate chief confidentably justifying his decision to take a 62yearold drug and start charging 50 times its regular price from 13. 50 to 750. The drug startup made mar stin martin strel lrv elli look like gla glaxo smith kline, look like a poster boy. Since it has no counterpart, its developer, touring pharmaceuticals, can charge what they want. Even by a factor of 50. Successful drug company, profitable drug company. I see where it looks greedy but there are a lot offal truic of altruistic issues. Critics attack touring and others like it for this basic Business Model. These companies are simply acquiring all therapies and repackaging them and saying well now were going to set the price at this amount

Where Hardest Geezer Russ Cook ranks among outstanding human achievements

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.